Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 3
1948 3
1949 4
1950 2
1951 2
1952 4
1953 7
1954 10
1955 6
1956 5
1957 4
1959 1
1960 2
1961 2
1962 1
1963 3
1964 1
1965 3
1966 5
1967 8
1968 10
1969 3
1970 5
1971 6
1972 7
1973 8
1974 4
1975 9
1976 6
1977 2
1978 10
1979 6
1980 15
1981 7
1982 11
1983 4
1984 9
1985 13
1986 16
1987 12
1988 18
1989 44
1990 26
1991 36
1992 31
1993 40
1994 32
1995 38
1996 39
1997 24
1998 31
1999 27
2000 39
2001 43
2002 52
2003 54
2004 53
2005 59
2006 65
2007 74
2008 103
2009 118
2010 119
2011 128
2012 134
2013 133
2014 128
2015 122
2016 126
2017 119
2018 158
2019 143
2020 175
2021 166
2022 168
2023 188
2024 125

Text availability

Article attribute

Article type

Publication date

Search Results

3,065 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib in previously treated Waldenström's macroglobulinemia.
Treon SP, Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ, Rodig S, Zehnder JL, Aster JC, Harris NL, Kanan S, Ghobrial I, Castillo JJ, Laubach JP, Hunter ZR, Salman Z, Li J, Cheng M, Clow F, Graef T, Palomba ML, Advani RH. Treon SP, et al. Among authors: castillo jj. N Engl J Med. 2015 Apr 9;372(15):1430-40. doi: 10.1056/NEJMoa1501548. N Engl J Med. 2015. PMID: 25853747 Free article. Clinical Trial.
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: castillo jj. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Clinical Trial.
Multimodal spatiotemporal phenotyping of human retinal organoid development.
Wahle P, Brancati G, Harmel C, He Z, Gut G, Del Castillo JS, Xavier da Silveira Dos Santos A, Yu Q, Noser P, Fleck JS, Gjeta B, Pavlinić D, Picelli S, Hess M, Schmidt GW, Lummen TTA, Hou Y, Galliker P, Goldblum D, Balogh M, Cowan CS, Scholl HPN, Roska B, Renner M, Pelkmans L, Treutlein B, Camp JG. Wahle P, et al. Among authors: del castillo js. Nat Biotechnol. 2023 Dec;41(12):1765-1775. doi: 10.1038/s41587-023-01747-2. Epub 2023 May 8. Nat Biotechnol. 2023. PMID: 37156914 Free PMC article.
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
Tur C, Carbonell-Mirabent P, Cobo-Calvo Á, Otero-Romero S, Arrambide G, Midaglia L, Castilló J, Vidal-Jordana Á, Rodríguez-Acevedo B, Zabalza A, Galán I, Nos C, Salerno A, Auger C, Pareto D, Comabella M, Río J, Sastre-Garriga J, Rovira À, Tintoré M, Montalban X. Tur C, et al. Among authors: castillo j. JAMA Neurol. 2023 Feb 1;80(2):151-160. doi: 10.1001/jamaneurol.2022.4655. JAMA Neurol. 2023. PMID: 36534392 Free PMC article.
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.
Qiang L, Hoffman MT, Ali LR, Castillo JI, Kageler L, Temesgen A, Lenehan P, Wang SJ, Bello E, Cardot-Ruffino V, Uribe GA, Yang A, Dougan M, Aguirre AJ, Raghavan S, Pelletier M, Cremasco V, Dougan SK. Qiang L, et al. Among authors: castillo ji. Gastroenterology. 2023 Oct;165(4):874-890.e10. doi: 10.1053/j.gastro.2023.05.038. Epub 2023 May 30. Gastroenterology. 2023. PMID: 37263309 Free PMC article.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garcés JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. Jelinek T, et al. Among authors: castillo jj. J Clin Oncol. 2023 Mar 1;41(7):1383-1392. doi: 10.1200/JCO.22.01226. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315921 Free PMC article.
Proteomics of human spermatozoa.
Castillo J, de la Iglesia A, Leiva M, Jodar M, Oliva R. Castillo J, et al. Hum Reprod. 2023 Dec 4;38(12):2312-2320. doi: 10.1093/humrep/dead170. Hum Reprod. 2023. PMID: 37632247 Review.
Editorial: Epidemiological trends in hematological malignancies.
de Lima M, Castillo J, Merli M, Garcia-Gutierrez V. de Lima M, et al. Among authors: castillo j. Front Oncol. 2023 Feb 14;13:1151774. doi: 10.3389/fonc.2023.1151774. eCollection 2023. Front Oncol. 2023. PMID: 36865813 Free PMC article. No abstract available.
Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease.
Custodia A, Aramburu-Núñez M, Rodríguez-Arrizabalaga M, Pías-Peleteiro JM, Vázquez-Vázquez L, Camino-Castiñeiras J, Aldrey JM, Castillo J, Ouro A, Sobrino T, Romaus-Sanjurjo D. Custodia A, et al. Among authors: castillo j. Cells. 2023 Mar 22;12(6):962. doi: 10.3390/cells12060962. Cells. 2023. PMID: 36980302 Free PMC article. Review.
3,065 results